SIX ISSUES IN PHARMACEUTICALS

Andrew Lilico

Economic Affairs, 2006, vol. 26, issue 3, 33-38

Abstract: This article examines six key issues facing the pharmaceuticals industry that concern the appropriateness and effectiveness of markets, quasi‐markets and regulatory intervention in the sector. The article shows the prevalence of confused thinking in this area, both on the part of lobbyists for the industry and their opponents. It is contended that allowing market forces to operate within a legal or regulatory framework that protects intellectual property rights, promotes innovation and facilitates price competition will produce more socially beneficial outcomes than direct state intervention in the market.

Date: 2006
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1111/j.1468-0270.2006.00647.x

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bla:ecaffa:v:26:y:2006:i:3:p:33-38

Ordering information: This journal article can be ordered from
http://www.blackwell ... bs.asp?ref=0265-0665

Access Statistics for this article

Economic Affairs is currently edited by Philip Booth

More articles in Economic Affairs from Wiley Blackwell
Bibliographic data for series maintained by Wiley Content Delivery ().